Safety profile of
ICLUSIG (ponatinib) in Ph+ ALL
Explore ICLUSIG safety profile in Philadelphia chromosome-positive Acute Lymphoblastic Leukemia
Explore ICLUSIG safety profile in Philadelphia chromosome-positive Acute Lymphoblastic Leukemia
Comparable safety vs imatinib + chemotherapy in newly diagnosed Ph+ ALL by utilizing optimized dosing1,2